Long-Term Liabilities to Equity: Axogen Surgical (AXGN)

Official company branding of Axogen Surgical (AXGN)

AxoGen, Inc. (AXGN) develops innovative biomaterials and surgical tools through strategic partnerships with medical centers. This chart of the long-term debt-to-equity ratio is fixed at 0.07. Its status as a global leader in nerve regeneration ensures stable demand across clinics. Furthermore, high loyalty among expert staff and the recruitment of specialized managers guarantee high-quality business development.

Axogen Corp (AXGN): Long-Term Debt to Capital from 07/04/2022 to 10/28/2026

Comprehensive metric breakdowns and analytics for AxoGen, Inc. (AXGN)

- price and consensus price forecast:
Market Chart AxoGen Inc|AXGN - Price Target Chart
- market capitalization data:
Market Valuation AxoGen, Inc.|AXGN - Enterprise Value
- book capitalization data:
Net Asset Value per Share Axogen|AXGN - Book Capitalization|Market Cap to Net Assets Ratio axogeninc.com|AXGN - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient AxoGen, Inc.|AXGN - Long-Term Debt to Capital|Short-Term Debt to Capital axogeninc.com|AXGN - Company Debts|Debt to Book Capitalization Ratio AxoGen, Inc.
Comprehensive company analysis:AXGN, AxoGen Inc
Core merchandise of AxoGen, Inc.

To assess the fundamental stability of AxoGen, Inc. (AXGN), it is critical to analyze the proportion of liabilities with a maturity exceeding one year relative to equity. The current long-term debt-to-equity ratio reflects the degree of financial leverage, allowing investors to evaluate the risk of default or the underutilization of borrowed funds. Given the significant expenditures on promotion and surgeon training, this indicator confirms the company's ability to finance expansion without incurring a critical debt load.

Direct competitors

Ratio of Long-Term Indebtedness to Capital BSX|EW - Long-Term Debt to Equity|Long-Term Liabilities to Equity ResMed Corporation (RMD)|PODD: Long-Term Debt to Capital|Long-Term Liabilities to Capital Zimmer ZBH|COO: Long-Term Debt to Capital|ALGN - Long-Term Debt to Equity Ratio|Globus Medical Corp - Long-Term Debt to Capital|TransMedics Group, Inc. (TMDX) - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital AORT|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity Integra LifeSciences Corp (IART)|Long-Term Debt to Capital ESTA|BBNX - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio IRADIMED CORPORATION|EMBC - Long-Term Liabilities to Equity|Long-Term Debt to Capital TNDM|SI-BONE Inc (SIBN) - Long-Term Liabilities to Capital|Long-Term Debt to Capital Orthofix International (OFIX)|Long-Term Debt to Capital Ratio Bioventus Global (BVS)|OrthoPediatrics Corp. (KIDS) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient TMCI (treace.com)|Strata Critical Medical - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Carlsmed, Inc. CARL|RXST (RxSight Corp) - Long-Term Debt to Capital|CLPT - Long-Term Liabilities to Capital|Long-Term Debt to Capital Stereotaxis, Inc.|neurostar.com (STIM) - Long-Term Debt to Capital Ratio|SGHT: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Orchestra BioMed Inc.|Long-Term Debt to Capital ANIK (Anika Therapeutics)|Long-Term Debt to Equity Ratio InspireMD Inc. (NSPR)|Long-Term Debt to Capital ZJYL (Jin Medical)|Vivani Medical Inc - Long-Term Debt to Capital|XTNT - Long-Term Debt to Equity|NeuroOne (NMTC) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio modular-medical.com MODD|Myomo Inc (MYO) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital COCH (Envoy Medical, Inc.)|Long-Term Liabilities to Capital VVOS|NVNO: Long-Term Debt to Equity|Long-Term Indebtedness to Equity sintx.com SINT|Long-Term Debt to Equity Ratio TNON (Tenon Medical, Inc)|Long-Term Debt to Capital Lifeward Ltd. LFWD|Long-Term Debt to Capital AMIX (Autonomix)|IVF: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Bone Biologics Corp (BBLG)|AXNX (Axonics Inc.) - Long-Term Liabilities to Equity|Long-Term Debt to Equity BIOL|Long-Term Debt to Equity Ratio Dynatronics Corp.|Paragon 28, Inc. - Long-Term Debt to Capital|Long-Term Liabilities to Capital INVO (invobioscience.com)